Population-based strategy for improving informed decision making about hormone replacement therapy in managed care settings

Women's Health Issues

Volumn 9, Issue 6, 1999, Pages 306-318

  Lacroix, Andrea Z ^a,b,c   Newton, Katherine M ^a,c   Buist, Diana S M ^a,c   Curry, Susan J ^a,c   Scholes, Delia ^a,c   Anderson, Lynda A ^d   Keenan, Nora L ^d  

^a CENTER FOR HEALTH STUDIES   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c Health Services and Epidemiology   (United States)

^d NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ATTITUDE; BREAST CANCER; COUNSELING; DECISION MAKING; DEPRESSION; DIABETES MELLITUS; FEMALE; HEALTH CARE AVAILABILITY; HEALTH STATUS; HORMONE SUBSTITUTION; HOT FLUSH; HUMAN; INSOMNIA; MENOPAUSE; OSTEOPOROSIS; SMOKING; STATISTICAL ANALYSIS;

EID: 0032741320     PISSN: 10493867     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1049-3867(99)00023-7     Document Type: Article

References (30)

1. Centers for Disease Control and Prevention. CDC Wonder Census System. [http://wonder.CDC.gov/WONDER], March 1999.
2. U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Alexandria, VA: International Medical Publishing, 1996.
3. U.S. Department of Health and Human Services. Healthy people 2000. DHHS Publication No. (PHS) 91-50212.
4. Newton K.M., LaCroix A.Z., Leveille S.G., Rutter C., Keenan N.L., Anderson L.A. Women's beliefs and decisions about hormone replacement therapy. J Women's Health. 6:1997;459-465.
5. Buist D.S.M., LaCroix A.Z., Newton K.M., Keenan N.L. Are long-term hormone replacement therapy users different than non-users? Am J Epidemiol. 149:1999;275-281.
6. Walsh J.M., McPhee S.J. A systems model of clinical preventive care an analysis of factors influencing patient and physician . Health Educ Q. 19:1992;157-175.
7. Newton K.M., LaCroix A.Z., Leveille S.G., Rutter C., Keenan N.L., Anderson L.A. The physician's role in women's decision making about hormone replacement therapy. Obstet Gynecol. 92:1998;5804.
8. Anderson L.A., Caplan L.S., Buist D.S.M., Newton K.M., Curry S.J., Scholes D., LaCroix A.Z. Perceived barriers and recommendations concerning hormone replacement counseling among primary care providers. Menopause. 6:1999;161-166.
9. Woods N.F., Falk S., Saver B., Taylor T.R., Stevens N., MacLaren A. Deciding about hormone therapy validation of a model . Menopause. 5:1998;52-59.
10. Holmes-Rovner M., Kroll J., Schmitt N., Rovner D.R., Breer L., Rothert M.L., Padonu G., Talarczyk G. Patient satisfaction with health care decisions the Satisfaction with Decision Scale . Med Decis Making. 16:1996;58-64.
11. Salamone L.M., Pressman A.R., Seeley D.G., Cauley J.A. Estrogen replacement therapy a survey of older women's attitudes . Arch Intern Med. 156:1996;1293-1297.
12. Johannes C.B., Crawford S.L., Posner J.G., McKinlay S.M. Longitudinal patterns and correlates of hormone replacement therapy use in middle-aged women. Am J Epidemiol. 140:1994;439-452.
13. Walsh J.M.E., Brown J.S., Rubin S., Kagawa M., Grady D. Postmenopausal hormone therapy factors influencing women's decision-making . Menopause. 4:1997;39-45.
14. Woods N.F., Saver B., Taylor T. Attitudes towards menopause and hormone therapy among women with access to health care. Menopause. 5:1998;178-188.
15. McNagny S.E., Jacobson T.A. Use of postmenopausal hormone replacement therapy by African American women the importance of physician discussion . Arch Intern Med. 157:1997;1337-1342.
16. Holmes-Rovner M., Padonu G., Kroll J., Breer L., Rovner D.R., Talarczyk G., Rothert M. African-American women's attitudes and expectations of menopause. Am J Prev Med. 12:1996;420-423.
17. Greendale G.A., Carlson K.J., Schiff I. Estrogen and progestin therapy to prevent osteoporosis attitudes and practices of general internists and gynecologists . J Gen Intern Med. 5:1990;464-469.
18. Seto T.B., Taira D.A., Davis R.B., Safran C., Phillips R.S. Effect of physician gender on the prescription of estrogen replacement therapy. J Gen Intern Med. 11:1996;197-203.
19. Exline J.L., Siegler I.C., Bastian L.A. Differences in providers' beliefs about benefits and risks of hormone replacement therapy in managed care. J Women's Health. 7:1998;879-884.
20. Hemminki E., Topo P., Malin M., Kangas I. Physicians' views on hormone therapy around and after menopause. Maturitas. 16:1993;163-173.
21. Saver B.G., Taylor T.R., Woods N.F., Stevens N.G. Physician policies on the use of preventive hormone therapy. Am J Prev Med. 13:1997;358-365.
22. Hulley S., Grady D., Bush T., Furberg C., Herrington D., Riggs D., Vittinghoff E. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/Progestin Replacement Study (HERS) Research Group. JAMA. 280:1998;605-613.
23. O'Connor A.M., Tugwell P., Wells G.A., Elmslie T., Jolly E., Hollingworth G., McPherson R., Bunn H., Graham I., Drake E. A decision aid for women considering hormone therapy after menopause decision support framework and evaluation . Patient Educ Counsel. 33:1998;267-279.
24. O'Connor A.M., Tugwell P., Wells G.A., Elmslie T., Jolly E., Hollingworth G., McPherson R., Drake E., Hopman W., MacKenzie T. Randomized trial of a portable, self-administered decision aid for postmenopausal women considering long-term preventive hormone therapy. Med Decis Making. 18:1998;295-303.
25. Rothert M.L., Holmes-Rovner M., Rovner D., Kroll J., Breer L., Talarczyk G., Schmitt N., Padonu G., Wills C. An educational intervention as decision support for menopausal women. Res Nurs Health. 20:1997;377-387.
26. Liao K.L., Hunter M.S. Preparation for menopause prospective evaluation of a health education intervention for middle-aged women . Maturitas. 29:1998;215-224.
27. Cummings S.R., Black D.M., Thompson D.E., Applegate W.B., Barrett-Connor E., Musliner T.A., Palermo L., Prineas R., Rubin S.M., Scott J.C., Vogt T., Wallace R., Yates A.J., LaCroix A.Z. Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures results from the Fracture Intervention Trial . JAMA. 280:1998;2077-2082.
28. Delmas P.D., Bjarnason N.H., Mitlak B.H., Ravoux A.C., Shah A.S., Huster W.J., Draper M., Christiansen C. Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women. N Engl J Med. 337:1997;1641-1647.
29. Khovidhunkit W., Shoback D.M. Clinical effects of raloxifene hydrochloride in women. Ann Intern Med. 130:1999;431-439.
30. Mort E.A. Clinical decision-making in the face of scientific uncertainty hormone replacement therapy as an example . J Fam Pract. 42:1996;147-151.